Kazia Therapeutics launches proposed public offering of ordinary shares
August 28, 2026 | 16:09
Oncology company Kazia Therapeutics initiated a proposed public equity offering to fund clinical advancement across its pipeline of targeted cancer and anti-tumour therapies.
Mobile Version